Skip to main content
Premium Trial:

Request an Annual Quote

Solexa Receives 700,000 UK Grant to Co-Develop Comparative Genomics Platform

NEW YORK, March 2 (GenomeWeb News) - Solexa has won more than ₤700,000 ($1.3 million) in funding from the UK government to co-develop a comparative genome analysis platform, the company said last week.

 

The aim of the project, a collaboration between the European Bioinformatics Institute, Imperial College London, the Wellcome Trust Sanger Institute, and Solexa, is to develop new bioinformatics tools for the comparative analysis of whole genome data. It will include enabling the Ensembl software system to handle whole genome sequences from several individuals, and developing new statistical tools for analyzing whole genome data.

 

The total budget for the project, expected to start in April, is ₤1.53 million, which includes contributions from Solexa. The company received the government grant under the LINK program from the UK's Department of Trade and Industry and the Medical Research Council.

 

Solexa, based in Cambridge, UK, is developing technology for the analyzing individual genomes quickly and economically.

 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.